BASF India logged a strong 24% year-on-year (YoY) increase in consolidated revenue from operations, reaching Rs. 4,832.19 crore
The stellar corporate performance was propelled by strong operations and robust revenues
Specialty chemicals giant expects full-year earnings to land in the upper half of its guidance range
Despite the margin pressure, Clariant maintained its full-year 2026 guidance, backed by a strong order book, particularly in Catalysts
The company reported a widened consolidated net loss of Rs. 28.08 crore for Q2 FY27
The company's consolidated revenue from operations climbed 22.1% YoY to Rs. 729.4 crore
This exceptional growth propelled the EBITDA margin up by 794 basis points to 14.72%
In Q3, the company delivered operating cash flow of $538 million and free cash flow of $461 million.
Advantaged investments, technology, and $16.9 billion in structural cost savings since 2019 are expanding our earnings power
The global agricultural leader registered group sales of $17.3 billion for the first nine months of the year
The numbers underline the company's ability to sustain profitable growth despite challenging global headwinds
Neogen, however, continued to face cost pressures arising from the Dahej plant rebuild, tolling arrangements, capital expenditure at NIL and elevated input costs
The most notable highlight of the quarter was the PAT which skyrocketed by an extraordinary 1,259%
The company's operating revenue, however, surged 40.9% year-on-year to Rs 2,773 crore in Q2 FY27
Revenue from operations, however, surged 116.51% year-on-year to Rs 272.88 crore
The company reported a consolidated revenue of Rs 346.7 crore in Q2 FY27
The next product planned for commercialization is N-Methyl Morpholine
Board approves Rs. 70 crore CapEx plan
Consolidated revenue from operations jump 104.9% year-on-year to Rs.934.37 crore
Revenue from operations grew by 13.3% YoY to reach Rs. 826 crore
Subscribe to our newsletter & stay updated.
